Back
Day Range
$22.71
$24.98
52-Week Range
$5.89
$55.65
Volume
17,083
50D / 200D Avg
$25.90
/
$31.71
Prev Close
$23.19
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 439.5 | 0.3 |
| P/B | 60.7 | 3.0 |
| ROE % | 14.8 | 3.7 |
| Net Margin % | 29.0 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
No forward estimates available
No quarterly estimates available
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
ROE of 14.83% — decent returns on equity
Net margin of 28.99% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Generating 2.08M in free cash flow
P/E of 439.50 — premium valuation
PEG of 0.40 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)21.95%
Earnings (1Y)5.29%
FCF Growth (3Y)-31.62%
Quality
Return on Equity
14.83%
ROIC8.71%
Net Margin28.99%
Op. Margin24.38%
Safety
Debt / Equity
0.00
Current Ratio10.71
Interest Coverage0.00
Valuation
P/E Ratio
439.50
Forward P/EN/A
P/B Ratio60.66
EV/EBITDA516.74
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21.95% | Revenue Growth (3Y) | -41.04% |
| Earnings Growth (1Y) | 5.29% | Earnings Growth (3Y) | -51.32% |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 8.19M | Net Income (TTM) | 2.37M |
| ROE | 14.83% | ROA | 12.54% |
| Gross Margin | 71.90% | Operating Margin | 24.38% |
| Net Margin | 28.99% | Free Cash Flow (TTM) | 2.08M |
| ROIC | 8.71% | FCF Growth (3Y) | -31.62% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 10.71 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 439.50 | Forward P/E | N/A |
| P/B Ratio | 60.66 | P/S Ratio | 127.41 |
| PEG Ratio | 0.40 | Forward PEG | N/A |
| EV/EBITDA | 516.74 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 0.20% | ||
| Market Cap | 1.04B | Enterprise Value | 1.03B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | 8.19M | 6.71M | 23.54M | 4.43M |
| Net Income | 2.37M | 2.25M | 10.01M | 2.54M |
| EPS (Diluted) | 0.06 | 0.01 | 0.07 | 0.03 |
| Gross Profit | 5.89M | 3.36M | 12.56M | 2.54M |
| Operating Income | 2.00M | 1.96M | 10.20M | 2.46M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Total Assets | 18.92M | 15.81M | 13.96M | 4.92M |
| Total Liabilities | 1.73M | 993,060.0 | 1.41M | 2.38M |
| Shareholders' Equity | 17.19M | 14.82M | 12.55M | 2.54M |
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash & Equivalents | 11.76M | 9.69M | 7.10M | 4.18M |
| Current Assets | 18.53M | 15.75M | 13.94M | 4.92M |
| Current Liabilities | 1.73M | 993,060.0 | 1.41M | 2.38M |